◆ NeutralZTS
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
GlobeNewswire Inc.·
A securities class action lawsuit has been filed against Zoetis Inc. for allegedly making false and misleading statements about its Companion Animal products. The lawsuit claims the company failed to disclose weakening veterinarian adoption of Librela due to FDA safety warnings, significant market share losses in Simparica Trio to competitors, and declining market share in dermatology products Apoquel and Cytopoint. Investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026 may be entitled to compensation. The lead plaintiff deadline is July 27, 2026.
Read Full Article at GlobeNewswire Inc. →